Riel Roussopoulos
US approves first new Alzheimer's drug in 20 years
In March 2019, late-stage international trials of aducanumab, involving about 3,000 patients, were halted when analysis showed the drug, given as a monthly infusion, was not better at slowing the deterioration of memory and thinking problems than a dummy drug.
Published at Mon, 07 Jun 2021 16:54:51 +0000
Comments
Loading…